Explore By Subject Area   
Return Home
Menu

Patients as Partners in Clinical Research

Date: Mar 24, 2026 - Mar 26, 2026

Location: Boston, MA

Day Three: Wednesday, March 19, 2025
Showing Events in 1 Track from 09:00am to 09:10am
Morning Remarks Grand Ballroom
9:00AM - 9:10AM
Day Three Co-Chairs’ Welcome
Co-Chair:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Angi Gillen, MS, Senior Director, Head of Patient Experience, Global Development | Clinical Operations, Gilead Sciences
Showing Events in 1 Track from 09:10am to 10:30am
Morning Sessions Grand Ballroom
9:10AM - 9:35AM
Annual Keynote: How The implementation of Patient Engagement Practices and Solutions is Essential to Ensuring Drug Development Long-Term Economic Viability
Keynote Speaker:
Kenneth Getz, MBA, Executive Director & Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
9:35AM - 10:00AM
Bridging Patient Advocacy and Operational Execution: The Strategic Role of the Chief Patient Officer
Fireside Participants:
Stacy Hurt, MHA, MBA, Chief Patient Officer, Parexel International Inc
Liselotte Hyveled, MSc. Pharm, MBA, Chief Patient Officer, Novo Nordisk
10:00AM - 10:30AM
Engaging Patients in Payer and CMS Decisions: Shaping Access to Innovative Therapies
Panelists:
June Cha, PhD, MPH, Policy Director, Milken Institute
Lee Fleisher, MD, ML, Senior Advisor / Former CMO and Former Director of the Center for Clinical Standards and Quality, FasterCures Milken Institute / CMS
Campbell Hutton, SVP, Global Advocacy, Breakthrough T1D
Showing Events in 1 Track from 10:30am to 11:10am
Morning Networking Break
10:30AM - 11:10AM
Morning Break and Networking
Showing Events in 1 Track from 11:10am to 12:45pm
Morning Sessions Continued Grand Ballroom
11:10AM - 11:35AM
Practical Approaches for Incorporating Patient Preferences into Clinical, Regulatory, and Market Decision-Making
Speaker:
Barry Liden, JD, Director, Public Policy, USC Schaeffer Center for Health Policy & Economics
11:35AM - 11:55AM
Evaluating Inclusive Representation in Clinical Trials: ICER’s New Framework for Accountability and Improvement
Speaker:
Foluso Agboola, MBBS, MPH, VP, Research, Institute for Clinical and Economic Review (ICER)
11:55AM - 12:30PM
FDA Guidance Updates and New Patient Engagement Initiatives
Speakers:
Robyn Bent, RN, Director, Patient-Focused Drug Development (PFDD) Program, Center for Drug Evaluation and Research (CDER), FDA
Karen Jackler, MPH, Patient Engagement Program Manager, Center for Biologics Evaluation and Research (CBER), FDA
12:30PM - 12:45PM
Leadership Closing Remarks
Showing Events in 1 Track from 12:45pm to 12:45pm
End of Conference
12:45PM - 12:45PM
End of Conference
Showing Events in 1 Track from 09:00am to 09:10am
Morning Remarks
Grand Ballroom
9:00AM - 9:10AM
Day Three Co-Chairs’ Welcome
Co-Chair:
Mackenzie Abramson, MPH, Patient Advocate and Sr. Manager, Research Program Communications, Global Genes
Angi Gillen, MS, Senior Director, Head of Patient Experience, Global Development | Clinical Operations, Gilead Sciences
Showing Events in 1 Track from 09:10am to 10:30am
Morning Sessions
Grand Ballroom
9:10AM - 9:35AM
Annual Keynote: How The implementation of Patient Engagement Practices and Solutions is Essential to Ensuring Drug Development Long-Term Economic Viability
Keynote Speaker:
Kenneth Getz, MBA, Executive Director & Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
9:35AM - 10:00AM
Bridging Patient Advocacy and Operational Execution: The Strategic Role of the Chief Patient Officer
Fireside Participants:
Stacy Hurt, MHA, MBA, Chief Patient Officer, Parexel International Inc
Liselotte Hyveled, MSc. Pharm, MBA, Chief Patient Officer, Novo Nordisk
10:00AM - 10:30AM
Engaging Patients in Payer and CMS Decisions: Shaping Access to Innovative Therapies
Panelists:
June Cha, PhD, MPH, Policy Director, Milken Institute
Lee Fleisher, MD, ML, Senior Advisor / Former CMO and Former Director of the Center for Clinical Standards and Quality, FasterCures Milken Institute / CMS
Campbell Hutton, SVP, Global Advocacy, Breakthrough T1D
Showing Events in 1 Track from 10:30am to 11:10am
Morning Networking Break
10:30AM - 11:10AM
Morning Break and Networking
Showing Events in 1 Track from 11:10am to 12:45pm
Morning Sessions Continued
Grand Ballroom
11:10AM - 11:35AM
Practical Approaches for Incorporating Patient Preferences into Clinical, Regulatory, and Market Decision-Making
Speaker:
Barry Liden, JD, Director, Public Policy, USC Schaeffer Center for Health Policy & Economics
11:35AM - 11:55AM
Evaluating Inclusive Representation in Clinical Trials: ICER’s New Framework for Accountability and Improvement
Speaker:
Foluso Agboola, MBBS, MPH, VP, Research, Institute for Clinical and Economic Review (ICER)
11:55AM - 12:30PM
FDA Guidance Updates and New Patient Engagement Initiatives
Speakers:
Robyn Bent, RN, Director, Patient-Focused Drug Development (PFDD) Program, Center for Drug Evaluation and Research (CDER), FDA
Karen Jackler, MPH, Patient Engagement Program Manager, Center for Biologics Evaluation and Research (CBER), FDA
12:30PM - 12:45PM
Leadership Closing Remarks
Showing Events in 1 Track from 12:45pm to 12:45pm
End of Conference
12:45PM - 12:45PM
End of Conference
Next
Day Three
Wednesday, March 19, 2025

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.